Patrick Aisher

Patrick Aisher serves as Director at Kinled Holding. He serves as Board Memebr of Aleva Neurotherapeutics. Currently he also serves as Investor at Oxford BioTherapeutics. He is a British-Austrian businessman who attended University in Montreal and London. Since 1992, he has specialised in starting and investing in engineering technology firms, taking a number to the London and New York stock exchanges. He is a Director of Kinled Holding, which owns shares in a portfolio of more than 20 technology, medical, property and luxury-goods companies. He is an individual member of the Swiss Corporate Finance and Private Equity Association. He is also a director of a number of private Swiss and Hong Kong-based funds that focus on engineering and medical devices, as well as a Charity in the U.K. that supports the under-privileged and unwell. He is also a partner at Sand Hill Investment Partners, which provides corporate finance services to RTH.